-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: Poster III

Symposia: Emerging Tools, Techniques, and Artificial Intelligence in Hematology Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Yiwei Zhou*, Zhiyuan Ma, PhD*, Shiang Huang, MD, Zhenhui Li*, Beining Lei*, Fang Zou*, Qijiao Li*, Liang Liang*, Li Sun* and Jie Zhang, MS*

Wuhan Kindstar Biotech Technology Co., Ltd, Wuhan, China

Jamin Wu, MD1*, Alec Chu, BS2*, Jang Cho, MD2*, Misha Movahed-Ezazi, MD1*, Kristyn Galbraith, MD1*, Chanel Schroff, BA1*, Yiying Yang, MS1*, Jon-Matthew Belton, PhD3*, Valentina Nardi, MD4*, Abner Louissaint, MD, PhD4*, Dennis Shasha, PhD5*, Tatyana Gindin, MD, PhD1*, Minji Kim, PhD6*, Marcin P Cieslik, PhD2*, Anthony Schmitt, PhD3*, Matija Snuderl, MD1* and Russell J. H. Ryan, MD2

1Department of Pathology, NYU Langone Health, New York, NY
2Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
3Arima Genomics, Carlsbad, CA
4Massachusetts General Hospital, Boston, MA
5Courant Institute of Mathematical Sciences, New York University, New York, NY
6Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI

Yuqing Wang1,2*, Shuo Wang1*, Hongmei Yi3*, Yue Wang1*, Haimin Xu3*, Shuang Tian1*, Yan Dong1*, Jing Zhao1*, Di Fu1*, Rongji Mu4*, Shuye Wang2*, Li Wang1*, Pengpeng Xu, MD1 and Wei Li Zhao, MD1

1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics; National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai, China
2Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China, Harbin, China
3Department of Pathology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai, China
4Department of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai, China

Dante Adami1*, Sebastian Riechert1*, Tim Schmittmann1*, Markus Badstübner, MSc1*, Karsten Wendt, PhD1,2,3*, Stefani Barbara Parmentier, MD4, Katja Sockel, MD5*, Frank P. Kroschinsky, MD, MBA5, Martin Bornhäuser, MD5,6,7*, Jan Moritz Middeke, MD1,2,5* and Jan-Niklas Eckardt1,8,9*

1Cancilico GmbH, Dresden, Germany
2Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, Germany
3Chair of Software Technology, Technical University Dresden, Dresden, Germany
4Tumorzentrum, St. Claraspital, Basel, Switzerland
5Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
6National Center for Tumor Diseases Dresden (NCT/UCC), Technical University Dresden, Dresden, Germany
7German Consortium for Translational Cancer Research DKFZ, Heidelberg, Germany
8Else Kroener Fresenius Center for Digital Health, TUD Dresden University of Technology, Dresden, Germany
9Department of Internal Medicine I, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany

Connor Kunihiro*, Dagmar Walter, PhD*, Yinzhou Zhu, PhD*, Kelly Martin, PhD*, Jawad Abousoud*, Tingsheng Drennon, PhD*, Nandhini Raman*, Veronica Rodriguez*, Yina Li*, Jill Herschleb, PhD* and Josephine Lee, PhD*

10x Genomics, Pleasanton, CA

Ka Young Kim, MD1*, Sung-Soo Park, MD, PhD1,2*, Na Yung Kim3*, Ji-Young Lim1,2*, Jung Yeon Lee1,2*, Sujin Yun3*, Yeun-Jun Chung3,4,5*, Seung-Hyun Jung3,5,6*, Jae-Ho Yoon, MD, PhD1, Hee-Je Kim1 and Chang-Ki Min1,2,3*

1Department of Hematology, Seoul St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Catholic Research Network for Multiple Myeloma, Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
4Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
5Integrated Research Center for Genome Polymorphism, Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
6Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

Szu-Ying Chen, PhD1*, Martin Cienciala2*, Tasfia Rashid1*, Bonell Patino Escobar3*, Laura Berne2*, Daniel Georgiev2* and Arun P Wiita, MD, PhD4,5,6,7

1Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
2Department of Research & Development, Sampling Human, Berkeley, CA
3University of California San Francisco, San Francisco, CA
4Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
5Chan Zuckerberg Biohub, San Francisco, CA
6Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA
7Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA

Curtis Gravenmier, MD1*, Sadegh Marzban2*, Ling Zhang, MD3*, Lynn C. Moscinski, MD4 and Jeffrey West, PhD2*

1Department of Hematopathology and Laboratory Medicine, Moffitt Cancer Center & Research Institute, Tampa
2Integrated Mathematical Oncology Department, Moffitt Cancer Center & Research Institute, Tampa, FL
3Hematopathology and Laboratory Medicine, Moffitt Cancer Center & Research Institute, Tampa, FL
4Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Arda Durmaz, PhD1*, Carlos Bravo-Perez, MD1,2*, Zachary Brady1*, Matteo D'Addona1,3*, Luca Guarnera, MD1,4*, Serhan Unlu, MD1, Hussein Awada1, Praveena Thiagarajan, MD, PhD1*, Yuriy Fedorov5*, Drew Adams6*, Carmelo Gurnari, MD, PhD4,7, Jacob G. Scott, MD, DPhil1*, Jaroslaw Maciejewski1 and Valeria Visconte, PhD8

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
3Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Ercolano, Italy
4Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
5Small Molecule Drug Development Core Facility, Case Western Reserve University School of Medicine, Cleveland
6Department of Genetics and Genome Sciences and Chemical Biology Program, Case Western Reserve University School of Medicine, Cleveland
7Cleveland Clinic Foundation, Cleveland, OH
8Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Saverio D'Amico, MSc1,2*, Mattia Delleani2*, Elisabetta Sauta, PhD2*, Gianluca Asti, MSc2*, Elena Zazzetti, MSc2*, Alessia Campagna2*, Luca Lanino, MD3, Giulia Maggioni, MD2*, Marta Ubezio, MD2*, Gabriele Todisco, MD4*, Antonio Russo, MD2*, Cristina Astrid Tentori, MD2*, Alessandro Buizza, MD2*, Marilena Bicchieri, PhD2*, Matteo Zampini, PhD3*, Matteo Brindisi3*, Francesca Ficara, PhD2*, Elena Riva, PhD3*, Denise Ventura, MSc3*, Laura Crisafulli, PhD3*, Nicole Pinocchio, MSc3*, Flavia Jacobs, MD2*, Alberto Zambelli, MD2*, Victor Savevski, MEng2*, Armando Santoro, MD5*, Tiziana Sanavia, PhD6*, Cesare Rollo, PhD6*, Flavio Sartori, MSc6*, Piero Fariselli, PhD6*, Guillermo Sanz, MD, PhD7, Valeria Santini, MD8, Francesc Sole, PhD9, Uwe Platzbecker, MD10, Pierre Fenaux, MD11, Maria Diez-Campelo, MD, PhD12*, Shahram Kordasti, MD, PhD13,14, Rami S. Komrokji, MD15, Guillermo Garcia-Manero, MD16, Torsten Haferlach, MD17, Amer M. Zeidan, MD18, Gastone Castellani, PhD19* and Matteo Giovanni Della Porta, MD2,20*

1Train s.r.l., Milan, Italy
2IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
3IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
4IRCCS Humanitas Research Hospital, Houston, TX
5IRCCS Humanitas Research Hospital, Rozzano, Italy
6Computational Biomedicine Unit, Department of Medical Sciences, University of Torino, Turin, Italy
7Hospital Universitario y Politécnico e Instituto de Investigación Sanitaria La Fe, Valencia, Spain
8MDS Unit, Hematology, AOUC, University of Florence, Florence, Italy
9Myelodysplastic Syndromes Research Group, Institut De Recerca Josep Carreras, Badalona, Barcelona, Spain
10Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
11Hôpital Saint-Louis, Université de Paris 7, Paris, France
12Hospital Clínico Universitario de Salamanca, Salamanca, Spain
13Hematology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Ancona, Italy
14Kings College London, London, United Kingdom
15Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
16Department of Leukemia, MD Anderson Cancer Center, Houston, TX
17MLL Munich Leukemia Laboratory, Munich, Germany
18Yale School of Medicine and Yale Comprehensive Cancer Center, Yale University, New Haven, CT
19Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy
20Department of Biomedical Sciences, Humanitas University, Milan, Italy

Erik R Sampson, PhD1*, Yi-Chien Chang, PhD1*, Kuan-Chun Huang, PhD1*, Tom Lin, MS1*, Prasanna Baskar, MS1*, Mei-Ling Yang, PhD1*, Ali Sepahi, PhD1*, Dobeen Hwang, PhD1*, Jack Huck, PhD1*, Ming-Tang Chen, PhD1*, Emily Huang1*, Ivana Grbesa, PhD2*, Francesco Lamanna, PhD2*, Andreas Kramer, PhD2*, Andrew Srisuwananukorn, MD3 and Lih-Ling Lin, PhD1*

1PharmaEssentia Innovation Research Center, Bedford, MA
2QIAGEN, LLC, Germantown, MD
3The Ohio State University, Columbus, OH

Paraic Behan1*, Sahin Sarihan, BSc1*, Megan Chiasson1*, Pir Zainulabdeen Jan Sarhandi1*, Joanna Fay2*, John P Quinn3*, Philip T Murphy3*, Katherine M Sheehan2* and Siobhan V Glavey1

1Departments of Haematology and Pathology, Beaumont RCSI Cancer Centre, Dublin, Ireland
2Department of Pathology, Beaumont RCSI Cancer Centre, Dublin, Ireland
3Department of Haematology, Beaumont RCSI Cancer Centre, Dublin, Ireland

Floris Chabrun, PhD, PharmD1*, Jean-Baptiste Alberge, PhD1, Sabine Allam, MD1*, Jacqueline F Perry1*, Habib El-Khoury, MD1*, David J Lee, MD1*, Michael Timonian, MD1*, Luca Bertamini, MD1*, Hadley Barr, BSc1*, Grace Fleming, BSc1*, Joseph Casey Flinn1*, Ciara Murphy1*, Sofia Wallin1*, Hiba Hussain2*, Elizabeth D. Lightbody, PhD1, Sungjae Kim, PhD3*, Mark C Perkins, PhD4*, Stephen J. Harding, PhD5, Dhananjay Sakrikar, PhD4*, Romanos Sklavenitis Pistofidis, MD, PhD1*, Kenneth C. Anderson, MD6, Omar Nadeem, MD7, Elizabeth K. O'Donnell8*, Yuxin Liu, MD9, Wenlong Chen10*, Maureen Joffe11*, Benjamin Levine Ebert, MD, PhD1, Catherine R. Marinac, PhD1, Gad Getz, PhD3* and Irene Ghobrial, MD12

1Dana-Farber Cancer Institute, Boston, MA
2Dana Farber Cancer Institute, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Thermo Fisher Scientific, Waltham, MA
5The Binding Site Inc., Birmingham, United Kingdom
6Dana-Farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
7Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA
8Dana Farber Cancer Institute, Boston
9Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
10University of the Witwatersrand, Johannesburg, ZAF
11University of the Witwatersrand, Johannesburg, South Africa
12Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Enayetur Raheem1*, Zheng Lu1*, Fred Zheng, MD2*, Limei Cheng1*, Peter Langmuir, MD2* and Jennifer Sheng, PhD1*

1Incyte Research Institute, Wilmington, DE
2Incyte Corporation, Wilmington, DE

Carlos Pérez Míguez1*, Adrian Mosquera Orgueira, MD, PhD2*, Manuel Perez Encinas, MD3*, Rebeca Rodriguez Veiga, MD, PhD4*, Juan Miguel Bergua Burgues, MD5*, Jesus Lorenzo Algarra6*, Carmen Botella7*, Jose Antonio Perez Simon8*, Teresa Bernal9,10,11*, Mar Tormo, MD12*, Maria Calbacho, MD13*, Olga Salamero, MD14,15*, Josefina Serrano, MD16*, Victor Noriega17*, Juan Antonio Lopez Lopez18*, Susana Vives, MD19*, Mercedes Colorado, MD20*, Jose Luis Lopez Lorenzo, MD21*, Maria Vidriales Vicente22*, Raimundo Garcia Boyero, MD23*, Maria Teresa Olave Rubio24*, Pilar Herrera Puente25*, Olga Arce, MD26*, Manuel Barrios Garcia27*, Maria Jose Sayas Lloris, MD28*, Marta Polo, MD29*, Maria Isabel Gomez Roncero30*, Eva Barragán, PhD31*, Rosa Ayala, MD, PhD32*, Carmen Chillon, MD33*, Maria Jose Calasanz, PhD34*, Blanca Boluda35*, Andres Peleteiro Raindo36*, Raquel Amigo37*, David Martinez-Cuadron, PhD38, Jorge Labrador, MD39* and Pau Montesinos, PhD, MD40*

1University Hospital of Santiago de Compostela, Department of Hematology, Santiago de Compostela, Spain, Santiago de Compostela, Spain
2University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain
3Department of Hematology, Hospital Unviersitario de Santiago de Compostela, IDIS, Santiago de Compostela, ESP
4Hospital Universitary i Politecnic La Fe, Valencia, ESP
5Hospital San Pedro de Alcántara, Caceres, Spain
66. Hospital General de Albacete, Albacete, Spain
7Hospital General Universitario de Alicante, Alicante, Spain
8University Hospital Virgen del Rocío, Sevilla, Spain
9Hospital Universitario Central de Asturias, Oviedo, Spain
10Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Asturias, Spain
11Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain
12Department of Hematology, Hospital Clínico de Valencia, Valencia, Spain
13Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Madrid, Spain
14Hematology Department, University Hospital Vall d’Hebron, Barcelona, Spain
15Experimental Hematology, Vall d’Hebron Institute of Oncology, Barcelona, Spain
16Department of Hematology, Hospital Universitario Reina Sofía, IMIBIC.UCO, Cordoba, ESP
17Hospital Clínico de A Coruña, A Coruña, Spain
18Hospital Universitario de Jaen, Jaen, Spain
19Hematology Department, Institut Catala d'Oncologia - Hospital Germans Trias i Pujol, Badalona, Spain
20Hematology Department, University Hospital Marques de Valdecilla, Santander, Spain
21Fundacion Jimenez Diaz, Madrid, ESP
22Hospital Universitario de Salamanca, Salamanca, Spain
23Hospital General Universitario de Castellon, Castellon, Spain
24Hospital Clinico Universitario Lorenzo Blesa, Zaragoza, ESP
25Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
26Hospital Universitario de Basurto, Bilbao, Spain
27Hospital Universitario Regional de Malaga, Malaga, Spain
28Hospital Dr. Peset, Valencia, Spain
29Department of Hematology, Hospital Universitario Clinico San Carlos, Madrid, Spain
30Hospital Virgen de la Salud, Toledo, Spain
31Hospital Universitary i Politecnic La Fe, Valencia, Spain
32Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
33Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
34Department of Hematology, Centre for Applied Medical Research, Cancer Center Clinica Universidad de Navarra, University of Navarra, IdiSNA, CIBERONC, Pamplona, Spain
35Hospital Universitari I Politècnic La Fe, Valencia, ESP
36University Hospital of Santiago De Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, ESP
37Instituto de Investigaciones Santiarias La Fe, Valencia, Spain
38Hematology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
39Department of Hematology, Hospital Universitario de Burgos, Universidad Isabel I, Burgos, Spain
40Hematology, Hospital Universitari I Politécnic La Fe and Programa Español de Tratamientos en Hematología (PETHEMA) Group, Valencia, Spain

Xinhua Wang1*, Zhiming Li, PhD, MD2, Yu Chang, MD3*, Shiyong Li4*, Wei Wu5*, Fangyuan Chang6*, Yinyin Chang7*, Dandan Zhu7*, Mingzhi Zhang, MD3 and Mao Mao, MD, PhD8

1The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
2Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
3The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
4"Research & Development, SeekIn Inc 11F, Building 2, DBH Life Sciences & Health Indust,518000", China, China
5Research & Development, SeekIn Inc 11F, Building 2, DBH Life Sciences & Health Indust,518000, Shenzhen, China
6Clinical Laboratories, Shenyou Bio, Zhengzhou, China
7Clinical Laboratories, Shenyou Bio, China, China
8Seekin, Shenzhen, China

Ai Guan, MD1*, Kaini Shen, MD2*, Wei Su3*, Bing Wang4*, Bin Ma, PhD5 and Jian Li, MD6

1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, CHN
3Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
4Shanghai Kuaixu Biotechnology Co., Ltd, Shanghai, China
5Rapid Novor Inc., Kitchener, ON, Canada
6Department of Hematology, Peking Union Medical College Hospital, Beijing, China

Gianluca Asti, MSc1*, Saverio D'Amico, MSc1,2*, Luciana Carota, PhD3*, Davide Piscia, MSc4*, Francesco Casadei, MSc5*, Nono Saha Cyrille Merleau, PhD6,7*, Patricia Alonso de Apellániz, MSc8*, Anne Sophie Kubasch, MD9, Silke Gloaguen, MSc9*, Nicole Modler, MSc9*, Catalina Gonzalez Martin, MSc10*, Cesare Rollo, PhD11*, Juan Parras, PhD8*, Mattia Delleani1*, Elena Zazzetti, MSc1*, Elisabetta Sauta, PhD1*, Nico Curti, PhD12*, Nicolas Riccardo Derus, PhD12*, Gianluca Carlini, PhD5*, Daniele Dall'Olio, PhD13*, Claudia Sala, PhD3*, Lorenzo Dall'Olio, PhD5,12*, Luca Lanino, MD14, Giulia Maggioni, MD1*, Alessia Campagna, MD1*, Marilena Bicchieri, PhD1*, Arturo Bonometti, MD1*, Cesare Lancellotti, MD15*, Daoud Rahal, MD1*, Luca Di Tommaso, MD1,16*, Tiziana Sanavia, PhD11*, Piero Fariselli, PhD11*, Matteo Zampini, PhD17*, Matteo Brindisi14*, Victor Savevski, MEng1*, Uwe Platzbecker, MD18, Maria Diez-Campelo, MD, PhD19*, Lin Pierre Zhao, MD, PhD20*, Pierre Fenaux, MD20, Torsten Haferlach, MD21, Vincent Planat, PhD10*, Raffaella Colombatti, MD, PhD22, Maria del Mar Mañú-Pereira, PhD23*, Anders Krogh, PhD24*, Silvia Uribe, PhD25*, Santiago Zazo, Prof., PhD8*, Enrico Giampieri, PhD3*, Gastone Castellani, PhD26*, Matteo Giovanni Della Porta, MD1,16* and Federico Alvarez, Prof, PhD8*

1IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
2Train s.r.l., Rozzano, Milan, Italy
3University of Bologna, Bologna, Italy
4Centro Nacional de Análisis Genómico - CNAG, Barcelona, Spain
5Data Science and Bioinformatics Laboratory, IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy
6Max Planck Institute for Mathematics in the Sciences, Leipzig, Germany
7Center for Scalable Data Analytics and Artificial Intelligence, University of Leipzig, Leipzig, Germany
8Information Processing and Telecommunications Center, Universidad Politécnica de Madrid, Madrid, Spain
9Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig, Germany
10Dedalus Spain, Madrid, Spain
11Computational Biomedicine Unit, Department of Medical Sciences, University of Torino, Turin, Italy
12Department of Physics and Astronomy, University of Bologna, Bologna, Italy
13IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
14IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
15Struttura Complessa di Anatomia Patologica, Policlinico di Modena, Modena, Italy
16Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
17IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy
18Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center, Leipzig, Germany
19Hospital Clínico Universitario de Salamanca, Salamanca, Spain
20Hôpital Saint-Louis, Université de Paris 7, Paris, France
21MLL Munich Leukemia Laboratory, Munich, Germany
22Department for Woman's and Child's Health, University of Padova, Padova, Italy
23Translational Research in Cancer and Blood disorders in Children, Valll d'Hebron Research Institution, Barcelona, Spain
24University of Copenhagen, Copenhagen, DNK
25Escuela Técnica Superior de Ingeniería de Sistemas Informáticos, Universidad Politécnica de Madrid, Madrid, Spain
26Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Byungsan Choi, PhD1*, Minsoo Kang, PhD1* and Janghee Woo, MD, PhD2

1PROTEINA Co., Ltd., Seoul, Korea, Republic of (South)
2Winship Cancer Institute of Emory University, Atlanta, GA

Palak Dave1*, Jordan Rai2*, Ling Zhang, MD3, Mohammad Omar Hussaini, MD4*, Mary Ellen Walker5*, Nancy Gillis, PhD6,7, Mikkael A. Sekeres, MD8, Amy E. DeZern, MD, MHS9, Eric Padron, MD10, Rami S. Komrokji, MD10 and Issam El Naqa11*

1Department of Machine Learning, H. Lee Moffitt Cancer and Research Institute, Wesley Chapel, FL
2Department of Machine Learning, H. Lee Moffitt Cancer and Research Institute, Tampa, FL
3Department of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer and Research Institute, Tampa, FL
4Department of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Department of Cancer Epidemiology, H. Lee Moffitt Cancer and Research Institute, tampa, FL
6Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, FL
7Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
9Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
10Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
11Department of Machine Learning, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Dylan C. Webb, BS1,2*, Cesar Colorado-Jimenez, MS1*, Maly Fenelus, MD, MPH1*, Siddharth Singi, MS3*, Zhanghan Yin, BS1,2*, Sean Paulsen, PhD1*, K. Hasan Bilal, MD4*, A. Zara Herskovitz, MD, PhD4*, Samuel McCash, MD1*, Linlin Wang, MD, PhD5*, Mikhail Roshal, MD, PhD1*, Lauren McVoy, MD, PhD1, Chad Vanderbilt, MD1*, Ahmet Dogan, MD, PhD3 and Gregory Mark Goldgof, MD, PhD1*

1Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Statistics, University of California, Berkeley, CA
3Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York
5Department of Laboratory Medicine, University of California-San Francisco, San Francisco

Shouvik Mani, MS1*, Fabian Grubert, MD, PhD2*, Dita Gratzinger, MD, PhD2*, Anshul Kundaje, PhD1,3* and Maya Kasowski, MD, PhD2,4*

1Department of Computer Science, Stanford University, Stanford, CA
2Department of Pathology, Stanford University School of Medicine, Stanford, CA
3Department of Genetics, Stanford University, Stanford, CA
4Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA

Borhan R. R Saeed, PhD1,2*, Anastasia Saboli, MSc1,3*, Anna Rehammar, PhD4*, Adam Molnar, MSc1*, Erik Delsing Malmberg, MD, PhD5*, Barbara Depreter, PhD6*, Giti Shah Barkhordar, MSc1,7*, Barbara De Moerloose, MD, PhD6,8,9*, Tim Lammens, PhD6,8,9*, Lars Palmqvist, MD, Professor10,11, Jonas Abrahamsson, MD, PhD, Professor3,12* and Linda Fogelstrand, MD1,3

1Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
2Department of Pathology and Neuropathology and Comprehensive Cancer Center, Tübingen University Hospital, Tuebingen, CA, Germany
3Region Vastra Gotaland, Sahlgrenska University Hospital, Gothenburg, Sweden
4School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
5Department of Pathology, Region Vastra Gotaland, Sahlgrenska University Hospital, Gothenburg, Sweden
6Department of Internal Medicine and Pediatrics, University of Ghent, Ghent, Belgium
7Department of Clinical Genetics and Genomics, Region Vastra Gotaland, Sahlgrenska University Hospital, Gothenburg, Sweden
8Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
9Cancer Research Institute Ghent (CRIG), Ghent, Belgium
10Department of Clinical Chemistry, Region Vastra Gotaland, Sahlgrenska University Hospital, Gothenburg, Sweden
11Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden
12Department of Pediatrics, Institute for Clinical Sciences, University of Gothenburg, Gothenburg, Sweden

Alex Liu, BSc1*, Severine Cathelin, PhD2*, Yitong Yang1*, Farzaneh Aboualizadeh3*, Amina Abow3*, Gurbaksh Basi3*, Lance Li1*, David L Dai1*, Abdula Maher4*, Eric Grignano, MD, PhD3*, Mohsen Hosseini, PhD2*, Dhanoop Manikoth Ayyathan, PhD2*, Vivian Wang1*, Troy Ketela, PhD3*, Dylan Marchione, PhD5*, Adriana Tron, PhD5*, Andrea Arruda3*, Mark D. Minden, MD, PhD1,3* and Steven M. Chan, MD, PhD1,6

1Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
2Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Princess Margaret Cancer Centre / University Health Network, Toronto, ON, Canada
4Institute of Medical Science, University of Toronto, Toronto, ON, Canada
5Servier Pharmaceuticals LLC, Boston, MA
6Princess Margaret Cancer Centre, Toronto, ON, Canada

Lydian A. De Ligt, MD1,2,3*, Eelke Brandsma2*, Aafke E. Gaartman2,4*, Guusje Van Gameren2*, Colin Blans2*, Martijn Veldthuis2*, Hanke Matlung2*, Bart J. Biemond4, Erfan Nur2,4*, Emile Van Den Akker2* and Robin van Bruggen2*

1Department of Hematology, Amsterdam University Medical Centers, Amsterdam, AL, Netherlands
2Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
3Department of Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, Netherlands
4Department of Hematology, Amsterdam University Medical Centers, Amsterdam, Netherlands

*signifies non-member of ASH